Welcome to CDC Stacks | SARS Vaccine Protective in Mice - 14732 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
SARS Vaccine Protective in Mice
  • Published Date:
    Aug 2005
  • Source:
    Emerg Infect Dis. 11(8):1312-1314.
Filetype[PDF - 53.71 KB]


No Related Documents.
You May Also Like:
  1. A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice
    Personal Author:
    Weger-Lucarelli, James; Chu, Haiyan; Aliota, Matthew T.; Partidos, Charalambos D.; Osorio, Jorge E.;
    Published:
    Jul 24 2014
    Source:
    PLoS Negl Trop Dis. 2014; 8(7).
    Description:
    Background : Chikungunya virus (CHIKV) is a re-emerging arbovirus associated with febrile illness often accompanied by rash and arthralgia that may persist for several years. Outbreaks are associated with high morbidity and create a public health cha...
    File Type:
    Filetype[PDF - 16.33 MB]
  2. A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice
    Personal Author:
    Steitz, Julia; Barlow, Peter G.; Hossain, Jaber; Kim, Eun; Okada, Kaori; Kenniston, Tom; Rea, Sheri; Donis, Ruben O.; Gambotto, Andrea;
    Published:
    May 05 2010
    Source:
    PLoS One. 5(5).
    Description:
    Background : In 2009 a new pandemic disease appeared and spread globally. The recent emergence of the pandemic influenza virus H1N1 first isolated in Mexico and USA raised concerns about vaccine availability. We here report our development of an aden...
    File Type:
    Filetype[PDF - 349.97 KB]
  3. DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice
    Personal Author:
    Epstein, Suzanne L.; Tumpey, Terrence M.; Misplon, Julia A.; Lo, Chia-Yun; Cooper, Lynn A.; Subbarao, Kanta; Renshaw, Mary; Sambhara, Suryaprakash; Katz, Jacqueline M.;
    Published:
    Aug 2002
    Source:
    Emerg Infect Dis. 8(8):796-801.
    Description:
    Influenza vaccination practice, which is based on neutralizing antibodies, requires being able to predict which viral strains will be circulating. If an unexpected strain, as in the 1997 H5N1 Hong Kong outbreak, or even a pandemic emerges, appropriat...
    File Type:
    Filetype[PDF - 297.44 KB]
  4. SARS Vaccine Development
    Personal Author:
    Jiang, Shibo; He, Yuxian; Liu, Shuwen;
    Published:
    Jul 2005
    Source:
    Emerg Infect Dis. 11(7):1016-1020.
    Description:
    Developing effective and safe vaccines is urgently needed to prevent infection by severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV). The inactivated SARS-CoV vaccine may be the first one available for clinical use because it ...
    File Type:
    Filetype[PDF - 95.26 KB]
  5. Mice Susceptible to SARS Coronavirus
    Personal Author:
    Wentworth, David E.; Gillim-Ross, Laura; Espina, Noel; Bernard, Kristen A.;
    Published:
    Jul 2004
    Source:
    Emerg Infect Dis. 10(7):1293-1296.
    Description:
    Murine models of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) will greatly advance research on this emerging virus. When BALB/c mice were simultaneously inoculated intranasally and orally, replication of SARS-CoV was found in b...
    File Type:
    Filetype[PDF - 250.02 KB]